DUBLIN (dpa-AFX) - Accenture (ACN) has entered into an agreement to acquire Ookla. Headquartered in Seattle, Ookla operates a portfolio of globally recognized brands in connectivity. Terms of the ...
© Foto: Scottsdale Mint auf Unsplash (Symbolbild)Die Aktie eines Silberproduzenten, die innerhalb von zwölf Monaten um mehr als 400 Prozent zugelegt hat. Klingt das nach einem Traum? Bei First Majesti ...
Syntheia Corp. (CSE: SYAI) ("Syntheia" or the "Company"), a conversational AI technology company, is pleased to announce that, further to an agreement ...
Life science experts will explore AI integration, regulatory transformation, and sustainable access to innovation DIA, a global non-profit organisation of life science professionals, will bring ...
FRANKFURT (dpa-AFX) - Die Aktien aus dem deutschen Chemiesektor haben am Dienstag weiterhin besonders stark unter Iran-Krieg gelitten. Im Dax waren die Titel des Branchenriesen BASF und des Agrarchemi ...
A new renewable energy platform anchored with high-quality, contracted, utility scale solar and onshore wind assets All amounts are in U.S. dollars unless otherwise indicated VICTORIA, British ...
DUBLIN (dpa-AFX) - Ziff Davis, Inc. (ZD) has entered into a definitive agreement to sell its Connectivity division to Accenture for $1.2 billion in cash. The company anticipates that the division's ...
Die Spannung steigt: Der Pharma- und Agrarchemiekonzern Bayer legt am morgigen Mittwoch (4. März) seinen Geschäftsbericht für das abgelaufene Geschäftsjahr sowie einen Ausblick auf 2026 vor. Im ...
Die US-Aktienmärkte stehen laut Goldman Sachs vor einem schwierigen Weg, bevor eine nachhaltige Erholung einsetzen kann. Fragile Marktstimmung, volatile Kapitalflüsse, steigende Ölpreise und geopoliti ...
Borussia Dortmund's first team was unsuccessful in reaching the Round of 16 of the Champions League, which is a key assumption when management provides its guidance at the start of the financial year.
SynAct Pharma's FY25 results reflect a year of solid execution, highlighted by the continued advancement of lead asset resomelagon in the Phase IIb ADVANCE trial in rheumatoid arthritis (RA). With enr ...
Newport Beach, CA, March 03, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (NYSE American: BESS, BESSWS), a developer, owner, and operator of utility-scale and distributed battery energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results